StocksFin Logo
Aurora Cannabis Inc. country of incorporation
|
|
Mr. Michael Singer
|
1,338 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
Zealand Pharma A/S country of incorporation
|
|
Dr. Emmanuel Dulac Ph.D., PharmD, MBA
|
237 employees
NASDAQ | Healthcare | Biotechnology
Q123 reported Sep 30, 2022 Reporting Period
$49.26M -18% vs. Q122 Revenues Q123
-3.47% -108.2% vs. Q122 Gross Profit Margin
-104.75% ! -429.8% vs. Q122 Net Profit Margin
-36.69M ! -61.8% vs. Q122 Free Cash Flow Q123
$-0.17 ! -183.3% vs. Q122 EPS Q123
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q122
Q122 reported Mar 31, 2022 Reporting Period
$15.08M -68.5% vs. Q121 Revenues Q122
80.69% 60.2% vs. Q121 Gross Profit Margin
-1000% ! -97.4% vs. Q121 Net Profit Margin
-320.75M ! 12.9% vs. Q121 Free Cash Flow Q122
$-5.16 ! 10.7% vs. Q121 EPS Q122
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q122
Ratios
As of
Sep 30, 2022
Mar 31, 2022
Quick Ratio
2.48
3.68
Current Ratio
4.07
4.79
Cash Ratio
2.2
3.4
Price to Book
0.83
6.04
Price to Sales
9.37
100
Price to Earnings
-2.24
-4.81